Trade Summary

6 days ago, Azamian Bobak R., serving as President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 10,000 shares at $61.55 per share, for a total transaction value of $615,488.26. Following this transaction, Azamian Bobak R. now holds 847,991 shares of TARS.

This sale represents a 1.17% decrease in Azamian Bobak R.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, June 17, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 22, 2026 at 4:09 PM ET, 5 days after the trade was made.

Tarsus Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.